Literature DB >> 11811651

Chromosome 22q11 deletion syndrome (CATCH 22): neuropsychiatric and neuropsychological aspects.

Lena Niklasson1, Peder Rasmussen, Sólveig Oskarsdóttir, Christopher Gillberg.   

Abstract

Twenty children and young adults (age range 5 to 33 years, 12 females and eight males) with genetically confirmed 22q11 deletion syndrome (CATCH 22: Cardiac anomaly, Anomalous face, Thymus hypoplasia/aplasia, Cleft palate, and Hypocalcaemia), recruited from a large ongoing study, were given comprehensive assessments with a view to determining the pattern of neuropsychiatric and neuropsychological deficits thought to be part of the syndrome in many cases. IQ ranged between 46 and 100 with a mean score of 70. Half the group had an IQ <70. In 13 individuals, attention-deficit-hyperactivity disorder (ADHD), mainly inattentive or combined type in most cases, and/or autism spectrum problems were diagnosed. Many participants, even among those who had an IQ within the normal range and had neither ADHD nor autistic spectrum problems, showed a characteristic and pronounced behavioural profile with low mental energy, initiation difficulties, deficits in sustained attention, and social interaction (often augmented by limited facial expression and communication and speech problems).

Entities:  

Mesh:

Year:  2002        PMID: 11811651     DOI: 10.1017/s0012162201001645

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  32 in total

1.  22q11.2 deletion syndrome: are motor deficits more than expected for IQ level?

Authors:  Nancy J Roizen; Anne M Higgins; Kevin M Antshel; Wanda Fremont; Robert Shprintzen; Wendy R Kates
Journal:  J Pediatr       Date:  2010-06-19       Impact factor: 4.406

Review 2.  Should children with ADHD and normal intelligence be routinely screened for underlying cytogenetic abnormalities?

Authors:  E Stephen; A D Kindley
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

3.  Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11.2 deletion syndrome.

Authors:  Sarah E Fine; Alison Weissman; Marsha Gerdes; Jennifer Pinto-Martin; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel
Journal:  J Autism Dev Disord       Date:  2005-08

4.  Neuromotor deficits in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Samantha H Monk; Karen Kiley-Brabeck; Jananne Khuri; Maria Karayiorgou
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

5.  Age-dependent clinical problems in a Norwegian national survey of patients with the 22q11.2 deletion syndrome.

Authors:  Kari Lima; Ivar Følling; Kristin L Eiklid; Solveig Natvig; Tore G Abrahamsen
Journal:  Eur J Pediatr       Date:  2010-02-26       Impact factor: 3.183

Review 6.  Velocardiofacial syndrome: is there a neuropsychiatric phenotype?

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

7.  Prevalence of ADHD in children with velocardiofacial syndrome: a preliminary report.

Authors:  Karen Zagursky; Ronald A Weller; Naushad Jessani; Jawwad Abbas; Elizabeth B Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

Review 8.  A biologic model to study the genetics of psychotic, mood, and anxiety disorders: the velocardiofacial syndrome.

Authors:  Edith M Jolin; Elizabeth B Weller; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

9.  Deficits in mental state attributions in individuals with 22q11.2 deletion syndrome (velo-cardio-facial syndrome).

Authors:  Jennifer S Ho; Petya D Radoeva; Maria Jalbrzikowski; Carolyn Chow; Jessica Hopkins; Wen-Ching Tran; Ami Mehta; Nicole Enrique; Chelsea Gilbert; Kevin M Antshel; Wanda Fremont; Wendy R Kates; Carrie E Bearden
Journal:  Autism Res       Date:  2012-09-07       Impact factor: 5.216

Review 10.  The importance of understanding cognitive trajectories: the case of 22q11.2 deletion syndrome.

Authors:  Ann Swillen
Journal:  Curr Opin Psychiatry       Date:  2016-03       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.